Jupiter Neurosciences(JUNS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

JUNS Jupiter Neurosciences

Closed Martin Luther King, Jr. Day 01-16 16:00:00 EST

0.8587

-0.0034

-0.39%

盘后0.8900

+0.0313+3.65%

17:16 EST

High0.8900	Low0.8200	Vol57.67K
Open0.8780	D1 Closing0.8621	Amplitude8.12%
Mkt Cap29.56M	Tradable Cap12.77M	Total Shares34.43M
T/O49.06K	T/O Rate0.39%	Tradable Shares14.88M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"JUNS","market":"US","secType":"STK","nameCN":"Jupiter Neurosciences","latestPrice":0.8587,"timestamp":1768597200000,"preClose":0.8621,"halted":0,"volume":57667,"hourTrading":{"tag":"盘后","latestPrice":0.89,"preClose":0.8587,"latestTime":"17:16 EST","volume":360,"amount":315.392,"timestamp":1768601789814,"change":0.0313,"changeRate":0.03645,"amplitude":0},"delay":0,"changeRate":-0.003943858021111192,"floatShares":14876300,"shares":34426355,"eps":-0.230265,"marketStatus":"Closed Martin Luther King, Jr. Day","change":-0.0034,"latestTime":"01-16 16:00:00 EST","open":0.878,"high":0.89,"low":0.82,"amount":49064.223677,"amplitude":0.081197,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.230265,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1768899600000},"marketStatusCode":7,"adr":0,"listingDate":1733202000000,"exchange":"NASDAQ","adjPreClose":0.8621,"preHourTrading":{"tag":"盘前","latestPrice":0.87,"preClose":0.8621,"latestTime":"08:57 EST","volume":51,"amount":44.37,"timestamp":1768571836955,"change":0.0079,"changeRate":0.009164,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":0.89,"preClose":0.8587,"latestTime":"17:16 EST","volume":360,"amount":315.392,"timestamp":1768601789814,"change":0.0313,"changeRate":0.03645,"amplitude":0},"volumeRatio":0.5176264237761596},"requestUrl":"/m/hq/s/JUNS/tweets","defaultTab":"tweets","newsList":[{"id":"2593446321","title":"Jupiter Neurosciences Secures $1.86 Million Second Tranche Financing from Yorkville","url":"https://stock-news.laohu8.com/highlight/detail?id=2593446321","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593446321?lang=en_us&edition=fundamental","pubTime":"2025-12-24 06:30","pubTimestamp":1766529009,"startTime":"0","endTime":"0","summary":"Jupiter Neurosciences Inc. has entered into a financing arrangement under a Standby Equity Purchase Agreement  with Yorkville. On December 23, 2025, the company received $1,860,000 as the second tranche of a pre-paid advance, following stockholder approval. In exchange, Jupiter issued a second convertible promissory note to Yorkville. The agreement allows Jupiter, at its discretion, to direct Yorkville to purchase additional shares of its common stock up to a defined maximum amount, subject to the terms of the SEPA. The securities are being issued in reliance on an exemption from registration under the Securities Act.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jupiter Neurosciences Inc. published the original content used to genera","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251223:nNDL6vzJF1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","JUNS"],"gpt_icon":0},{"id":"2593458718","title":"Jupiter Neurosciences Inc. Held Annual Shareholder Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2593458718","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593458718?lang=en_us&edition=fundamental","pubTime":"2025-12-23 05:31","pubTimestamp":1766439077,"startTime":"0","endTime":"0","summary":"Jupiter Neurosciences Inc. held its 2025 Annual Meeting of Stockholders on December 19, 2025. Stockholders approved the Jupiter Neurosciences Inc. 2025 Equity Incentive Plan and an amendment to the company's certificate of incorporation to increase the number of authorized shares of common stock from 125,000,000 to 500,000,000.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jupiter Neurosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 22, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251222:nNDL29Gq6Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JUNS","BK4007"],"gpt_icon":0},{"id":"2588066274","title":"Jupiter Neurosciences to Present at NobleCon21 Emerging Growth Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2588066274","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588066274?lang=en_us&edition=fundamental","pubTime":"2025-12-03 05:15","pubTimestamp":1764710158,"startTime":"0","endTime":"0","summary":"Jupiter Neurosciences Inc. will participate in the Noble Capital Markets' 21st Annual Emerging Growth Equity Conference  on December 2-3, 2025, in Boca Raton, Florida. The company's management team will present at the event and be available for one-on-one meetings with members of the investment community.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jupiter Neurosciences Inc. published the original content used to generate this news brief via Newsfile  on December 02, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251202:nNDL7tcx8W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","JUNS"],"gpt_icon":0},{"id":"2586930162","title":"BRIEF-Jupiter Neurosciences Files Rospectus Related To Resale Of Up To 10 Million Shares Of Our Common Stock By Selling Stockholder","url":"https://stock-news.laohu8.com/highlight/detail?id=2586930162","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586930162?lang=en_us&edition=fundamental","pubTime":"2025-11-27 06:32","pubTimestamp":1764196340,"startTime":"0","endTime":"0","summary":"BRIEF-Jupiter Neurosciences Files Rospectus Related To Resale Of Up To 10 Million Shares Of Our Common Stock By Selling StockholderNov 26  - Jupiter Neurosciences Inc JUNS.O:JUPITER NEUROSCIENCES INC - FILES ROSPECTUS RELATED TO RESALE OF UP TO 10 MILLION SHARES OF OUR COMMON STOCK BY SELLING STOCKHOLDERSource text: [ID:n0001493152-25-025204]Further company coverage: JUNS.O ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251126:nFWN3X20LZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","JUNS"],"gpt_icon":0},{"id":"2586036293","title":"Jupiter Neurosciences Inc - Files Rospectus Related to Resale of up to 10 Mln Shares of Our Common Stock by Selling Stockholder","url":"https://stock-news.laohu8.com/highlight/detail?id=2586036293","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586036293?lang=en_us&edition=fundamental","pubTime":"2025-11-27 06:30","pubTimestamp":1764196228,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251126:nFWN3X20LZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["JUNS","BK4007"],"gpt_icon":0},{"id":"2585157743","title":"Jupiter Neurosciences Issues Amended SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2585157743","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585157743?lang=en_us&edition=fundamental","pubTime":"2025-11-21 05:06","pubTimestamp":1763672782,"startTime":"0","endTime":"0","summary":"Jupiter Neurosciences Inc. has filed an amendment to its previously issued Form 8-K report to update and correct information in Item 1.01. The amended report, filed on November 19, 2025, modifies details originally disclosed in the October 27, 2025 filing.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jupiter Neurosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 20, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251120:nNDL7wsBZZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","JUNS"],"gpt_icon":0},{"id":"2581706248","title":"Jupiter Neurosciences price target lowered to $25 from $30 at Greenridge","url":"https://stock-news.laohu8.com/highlight/detail?id=2581706248","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581706248?lang=en_us&edition=fundamental","pubTime":"2025-11-06 04:15","pubTimestamp":1762373754,"startTime":"0","endTime":"0","summary":"Greenridge analyst William Gregozeski lowered the firm’s price target on Jupiter Neurosciences (JUNS) to $25 from $30 and keeps a Buy rating on the...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/jupiter-neurosciences-price-target-lowered-to-25-from-30-at-greenridge-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/jupiter-neurosciences-price-target-lowered-to-25-from-30-at-greenridge-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["JUNS"],"gpt_icon":0},{"id":"2581247778","title":"Jupiter receives FDA clearance of IND application to initiate Phase 2 trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2581247778","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581247778?lang=en_us&edition=fundamental","pubTime":"2025-11-05 21:36","pubTimestamp":1762349790,"startTime":"0","endTime":"0","summary":"Jupiter Neurosciences (JUNS) announced that the U.S. Food and Drug Administration, FDA, has cleared its Investigational New Drug, IND, application ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/jupiter-receives-fda-clearance-of-ind-application-to-initiate-phase-2-trial-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/jupiter-receives-fda-clearance-of-ind-application-to-initiate-phase-2-trial-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","JUNS"],"gpt_icon":0},{"id":"2581778994","title":"BRIEF-Jupiter Neurosciences Receives FDA Clearance of IND Application to Initiate Phase 2a Clinical Trial of JOTROL in Parkinson’s Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2581778994","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581778994?lang=en_us&edition=fundamental","pubTime":"2025-11-05 21:32","pubTimestamp":1762349530,"startTime":"0","endTime":"0","summary":"BRIEF-Jupiter Neurosciences Receives FDA Clearance of IND Application to Initiate Phase 2a Clinical Trial of JOTROL in Parkinson’s DiseaseNov 5 (Reuters) - Jupiter Neurosciences Inc JUNS.O:JUPITER NEU","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251105:nTUA1CWBXN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","JUNS"],"gpt_icon":0},{"id":"2581077869","title":"Jupiter Neurosciences Inc - Expects Trial Enrollment to Begin in Early 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2581077869","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581077869?lang=en_us&edition=fundamental","pubTime":"2025-11-05 21:30","pubTimestamp":1762349400,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251105:nTUA1CWBXN:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","JUNS"],"gpt_icon":0},{"id":"2578646732","title":"Jupiter Neurosciences Inc - Proceeds to Support Phase 2 Parkinson's Trial and Nugevia Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2578646732","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578646732?lang=en_us&edition=fundamental","pubTime":"2025-10-27 20:30","pubTimestamp":1761568201,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251027:nTUA6ZR1PN:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","JUNS"],"gpt_icon":0},{"id":"2578641221","title":"Jupiter Neurosciences Enters into Agreements for up to $20 Million in Flexible Financing","url":"https://stock-news.laohu8.com/highlight/detail?id=2578641221","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578641221?lang=en_us&edition=fundamental","pubTime":"2025-10-27 20:30","pubTimestamp":1761568200,"startTime":"0","endTime":"0","summary":"Financing designed to support Phase 2 Parkinson’s trial and accelerate Nugevia product line growth  Jupiter, FL, Oct.  27, 2025  (GLOBE NEWSWIRE) -- Jupiter Neurosciences, Inc (“JUNS” or the “Company”","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/10/27/3174574/0/en/Jupiter-Neurosciences-Enters-into-Agreements-for-up-to-20-Million-in-Flexible-Financing.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","JUNS"],"gpt_icon":0},{"id":"2576064012","title":"Jupiter Neurosciences Inc. Announces Date for Upcoming Annual Stockholders Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2576064012","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576064012?lang=en_us&edition=fundamental","pubTime":"2025-10-18 05:26","pubTimestamp":1760736387,"startTime":"0","endTime":"0","summary":"Jupiter Neurosciences, Inc. has announced that it will hold its 2025 Annual Meeting of Stockholders on December 12, 2025. The meeting will be conducted in a virtual format.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jupiter Neurosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on October 17, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251017:nNDL8jwz2c:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JUNS","BK4007"],"gpt_icon":0},{"id":"2567119063","title":"Jupiter Neurosciences Names Visionary Entrepreneur and Biohacker Jean Fallacara as Third Nugevia™ Brand Ambassador","url":"https://stock-news.laohu8.com/highlight/detail?id=2567119063","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567119063?lang=en_us&edition=fundamental","pubTime":"2025-09-15 20:00","pubTimestamp":1757937600,"startTime":"0","endTime":"0","summary":"Partnership strengthens Nugevia launch bringing clinical and scientific integrity to the fast-growing longevity space  Jupiter, Florida, Sept.  15, 2025  (GLOBE NEWSWIRE) -- Jupiter Neurosciences, Inc","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/09/15/3149961/0/en/Jupiter-Neurosciences-Names-Visionary-Entrepreneur-and-Biohacker-Jean-Fallacara-as-Third-Nugevia-Brand-Ambassador.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CNS","JUNS","BK4007","BK4135"],"gpt_icon":0},{"id":"2562736608","title":"Jupiter Neurosciences Launches Nugevia™ Website and Opens Pre-Orders for Groundbreaking Longevity Supplements","url":"https://stock-news.laohu8.com/highlight/detail?id=2562736608","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562736608?lang=en_us&edition=fundamental","pubTime":"2025-08-26 20:00","pubTimestamp":1756209600,"startTime":"0","endTime":"0","summary":"Targeting the Multi-Trillion Dollar Longevity Market Jupiter, Florida, Aug.  26, 2025  (GLOBE NEWSWIRE) -- Jupiter Neurosciences, Inc. (NASDAQ: JUNS) (“Jupiter” or the “Company”), a clinical-stage pha","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/08/26/3139219/0/en/Jupiter-Neurosciences-Launches-Nugevia-Website-and-Opens-Pre-Orders-for-Groundbreaking-Longevity-Supplements.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CNS","BK4135","BK4007","JUNS"],"gpt_icon":0},{"id":"2560519907","title":"Jupiter Neurosciences Names NBA Legend Chris Webber as Second Nugevia™ Brand Ambassador","url":"https://stock-news.laohu8.com/highlight/detail?id=2560519907","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560519907?lang=en_us&edition=fundamental","pubTime":"2025-08-19 20:12","pubTimestamp":1755605520,"startTime":"0","endTime":"0","summary":"Partnership expands momentum for launch of new longevity supplement line powered by clinical science and performance-driven innovation Jupiter, Florida, Aug.  19, 2025  (GLOBE NEWSWIRE) -- Jupiter Neu","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/08/19/3135668/0/en/Jupiter-Neurosciences-Names-NBA-Legend-Chris-Webber-as-Second-Nugevia-Brand-Ambassador.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CNS","BK4135","JUNS"],"gpt_icon":0},{"id":"2558650522","title":"Jupiter Neurosciences Introduces Nugevia™ MND: A Cognitive Health Supplement Leveraging Clinically Validated Neuroscience","url":"https://stock-news.laohu8.com/highlight/detail?id=2558650522","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558650522?lang=en_us&edition=fundamental","pubTime":"2025-08-11 20:00","pubTimestamp":1754913600,"startTime":"0","endTime":"0","summary":"MND combines proprietary resveratrol-based platform and NovaSOL Curcumin to enhance cognitive performance and support neuroprotective health Jupiter, Florida, Aug.  11, 2025  (GLOBE NEWSWIRE) -- Jupit","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/08/11/3130856/0/en/Jupiter-Neurosciences-Introduces-Nugevia-MND-A-Cognitive-Health-Supplement-Leveraging-Clinically-Validated-Neuroscience.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4135","BK4007","CNS","JUNS"],"gpt_icon":0},{"id":"2553248819","title":"Jupiter Neurosciences Highlights Critical Advancement of JOTROL™ Over Traditional Resveratrol with Breakthrough Bioavailability and CNS-Targeted Science","url":"https://stock-news.laohu8.com/highlight/detail?id=2553248819","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553248819?lang=en_us&edition=fundamental","pubTime":"2025-07-23 20:00","pubTimestamp":1753272000,"startTime":"0","endTime":"0","summary":"Transforming a promising molecule into a clinically viable therapeutic platform Jupiter, Florida, July  23, 2025  (GLOBE NEWSWIRE) -- Jupiter Neurosciences, Inc. (NASDAQ: JUNS) (\"Jupiter\" or the \"Comp","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/07/23/3120148/0/en/Jupiter-Neurosciences-Highlights-Critical-Advancement-of-JOTROL-Over-Traditional-Resveratrol-with-Breakthrough-Bioavailability-and-CNS-Targeted-Science.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LU2023250504.SGD","LU2265009873.SGD","LU1974910355.USD","BK4588","LU1093756168.USD","BK4135","PWR","LU1093756325.SGD","BK4129","JUNS","GLO","BK4007","LU2106854487.HKD","BK4567","LU1917777945.USD","LU2023250843.SGD","CNS","LU1261432733.SGD","LU1804176565.USD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.jupiterneurosciences.com","stockEarnings":[{"period":"1week","weight":-0.1899},{"period":"1month","weight":-0.2401},{"period":"3month","weight":-0.4599},{"period":"6month","weight":-0.4699},{"period":"1year","weight":-0.7989},{"period":"ytd","weight":-0.1581}],"compareEarnings":[{"period":"1week","weight":-0.0035},{"period":"1month","weight":0.0302},{"period":"3month","weight":0.041},{"period":"6month","weight":0.1021},{"period":"1year","weight":0.1691},{"period":"ytd","weight":0.0143}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"exchange":"NASDAQ","name":"Jupiter Neurosciences","nameEN":"Jupiter Neurosciences"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Jupiter Neurosciences(JUNS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Jupiter Neurosciences(JUNS) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Jupiter Neurosciences,JUNS,Jupiter Neurosciences股票,Jupiter Neurosciences股票老虎,Jupiter Neurosciences股票老虎国际,Jupiter Neurosciences行情,Jupiter Neurosciences股票行情,Jupiter Neurosciences股价,Jupiter Neurosciences股市,Jupiter Neurosciences股票价格,Jupiter Neurosciences股票交易,Jupiter Neurosciences股票购买,Jupiter Neurosciences股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Jupiter Neurosciences(JUNS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Jupiter Neurosciences(JUNS) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction